red spot at injection site tirzepatide reactions Injection Site Reaction Tirzepatide: Causes,

Both agents affect insulin sensitivity and glucose regulation, creating unpredictable risks including glucose dysregulation when used together

According to the Mounjaro Prescribing Information, these include nausea (17-22%), diarrhea (13-17%), decreased appetite (10-14%), vomiting (6-10%), constipation (5-7%), and dyspepsia (5-7%)

40 Chinese companies manufacture GLP-1 as of January 2026

Block, M.S

Patients using PlexusDx compounded semaglutide can expect the same appetite reduction, metabolic effects, and weight loss trajectory as those using Ozempic or Wegovy

The absence of IGF-1 stimulation is particularly relevant for long-term safety